Erythropoietin in Radiation Oncology - A Review - 1st International Conference, Freiburg, June 11-12, 1999

The therapeutic potential of erythropoietin gains increasing attention amon g radiation oncologists because the prognosis is better for patients with h igh blood hemoglobin levels following radiotherapy. However, there is still a debate on how hemoglobin affects radiotherapy. Further, the means to man ipulate the hemoglobin level, their indication and administration need to b e clarified. Available experimental and clinical data on hypoxia, anemia an d on their treatment with erythropoietin have been extensively discussed at an international conference in Freiburg, Germany, in June 1999. This repor t gives a summary reviewing the topic. Copyright (C) 2000 S. Karger AG. Bas el